St. Elizabeth Healthcare Is anxiety a mood disorder or is it a physical reaction to emotional stress? The answer is that it ...

AbbVie has returned to the source of its antipsychotic powerhouse Vraylar in search of another blockbuster, paying $25 ...

AbbVie (ABBV) and Gedeon Richter announced a new discovery, co-development and license agreement to advance novel targets for the potential ...

A Duloxetine recall by the FDA has flagged more than 7,100 bottles of the Cymbalta generic drug due to a cancerous chemical.

We are delighted to welcome Dr. Barbato to Incannex as our Chief Medical Officer. With an established track record in directing drug development through late-stage clinical trials and multiple product ...

Most of us have experienced anxiety or will at some point in the future. It's normal to feel worried from time to time.

Global Cannabis Use Disorder Treatment Market. The global cannabis use disorder treatment market is expected to grow from USD ...

The Boston-based biotech will use the new fundraise to develop its pipeline of drug candidates for conditions such as major ...

Launched by PureTech and backed by well-known venture capital firms, the startup has raised $325 million since its debut this spring.

“There are all these drugs, especially but not just in CNS ... Seaport’s pipeline also includes SPT-320 (formerly LYT-320), a ...

Miindfulness-based stress reduction may be as effective as escitalopram (Lexapro — an SSRI commonly used to treat depression ...

The musicians teamed up with sound therapists to create music that could lower the heart rate, blood pressure, and actual ...